ES2176805T3 - Empleo de mezclas de productos activos para la obtencion de agentes hipocolesterinemicos. - Google Patents

Empleo de mezclas de productos activos para la obtencion de agentes hipocolesterinemicos.

Info

Publication number
ES2176805T3
ES2176805T3 ES97950201T ES97950201T ES2176805T3 ES 2176805 T3 ES2176805 T3 ES 2176805T3 ES 97950201 T ES97950201 T ES 97950201T ES 97950201 T ES97950201 T ES 97950201T ES 2176805 T3 ES2176805 T3 ES 2176805T3
Authority
ES
Spain
Prior art keywords
agents
mixtures
hypocolesterinemic
obtaining
active products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97950201T
Other languages
English (en)
Inventor
Norbert Weitkemper
Bernd Fabry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Personal Care and Nutrition GmbH
Original Assignee
Cognis Deutschland GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26031678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2176805(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE19700796A external-priority patent/DE19700796C2/de
Application filed by Cognis Deutschland GmbH and Co KG filed Critical Cognis Deutschland GmbH and Co KG
Application granted granted Critical
Publication of ES2176805T3 publication Critical patent/ES2176805T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

PARA LA PREPARACION DE AGENTES CON EFECTO MEJORADO HIPOCOLESTEROLEMICO SE PROPONE LA UTILIZACION DE MEZCLAS, QUE CONTIENEN (A) ESTERES DE FITOSTANOL Y (B) TOCOFEROLES. MEDIANTE LA ENCAPSULACION EN GELATINA SE PUEDE ADMINISTRAR DICHOS AGENTES SIN PROBLEMA TAMBIEN DE MANERA ORAL EN DOSIS ELEVADAS.
ES97950201T 1996-11-28 1997-11-19 Empleo de mezclas de productos activos para la obtencion de agentes hipocolesterinemicos. Expired - Lifetime ES2176805T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19649286 1996-11-28
DE19700796A DE19700796C2 (de) 1996-11-28 1997-01-13 Wirkstoffmischungen zur Verminderung des Cholesteringehaltes im Serum von Warmblütern

Publications (1)

Publication Number Publication Date
ES2176805T3 true ES2176805T3 (es) 2002-12-01

Family

ID=26031678

Family Applications (2)

Application Number Title Priority Date Filing Date
ES97951916T Expired - Lifetime ES2182137T3 (es) 1996-11-28 1997-11-19 Empleo de mezclas de productos activos, que contienen fitoestenoles y/o esteres de fitoestenol y agentes potenciadores para la obtencion de agentes hipocolesterinemicos.
ES97950201T Expired - Lifetime ES2176805T3 (es) 1996-11-28 1997-11-19 Empleo de mezclas de productos activos para la obtencion de agentes hipocolesterinemicos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES97951916T Expired - Lifetime ES2182137T3 (es) 1996-11-28 1997-11-19 Empleo de mezclas de productos activos, que contienen fitoestenoles y/o esteres de fitoestenol y agentes potenciadores para la obtencion de agentes hipocolesterinemicos.

Country Status (10)

Country Link
US (1) US6383514B1 (es)
EP (2) EP0941097B1 (es)
JP (2) JP2001508046A (es)
AU (2) AU714993B2 (es)
CA (2) CA2273341A1 (es)
DK (2) DK0952837T3 (es)
ES (2) ES2182137T3 (es)
NO (2) NO992562L (es)
NZ (1) NZ335990A (es)
WO (2) WO1998023275A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0594612B2 (en) 1991-05-03 2010-02-24 Raisio Nutrition Ltd. Process for the preparation of a substance comprising a beta-sitostanol fatty acid ester or a mixture thereof
DE19750422C1 (de) * 1997-11-14 1998-11-26 Henkel Kgaa Verwendung von ausgewählten Phytostenolestern zur Herstellung von hypocholesterinämischen Mitteln
US6242001B1 (en) * 1998-11-30 2001-06-05 Mcneil-Ppc, Inc. Method for producing dispersible sterol and stanol compounds
EP1064912B1 (de) * 1999-07-02 2004-01-28 Cognis Iberia, S.L. Mikrokapseln - I
US6677327B1 (en) 1999-11-24 2004-01-13 Archer-Daniels-Midland Company Phytosterol and phytostanol compositions
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0329667D0 (en) * 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
GB0513881D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
EP1600062A1 (en) * 2004-05-25 2005-11-30 Cognis IP Management GmbH Oral and/or topical compositions comprising prebiotics and sterols
GB0512726D0 (en) * 2005-06-22 2005-07-27 Btg Int Ltd Multiple sclerosis therapy and diagnosis
GB0513888D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
GB0513883D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Diagnosis of Atherosclerosis
US9637515B2 (en) * 2006-11-06 2017-05-02 Jina Pharmaceuticals, Inc. Guggulphospholipid methods and compositions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3085939A (en) 1959-05-11 1963-04-16 Upjohn Co Oil-in-water emulsion for oral administration, and process for preparation
US3203862A (en) 1960-03-11 1965-08-31 Jones John Harris Oral anti-hypercholesterol composition
US3089939A (en) 1960-04-06 1963-05-14 Kamborian Dip-type adhesive container
CA928140A (en) 1969-07-17 1973-06-12 A. Erickson Billy Clear cooking and salad oils having hypocholesterolemic properties
JPS57206336A (en) 1981-06-12 1982-12-17 Ajinomoto Co Inc Edible oil
CA1185500A (en) 1981-08-12 1985-04-16 Joseph Z. Zdrok Disposable respirator
EP0195311B2 (en) 1985-03-06 1996-01-17 Yoshikawa Oil & Fat Co., Ltd. Process for preparing fatty acid esters
JPS62186936A (ja) 1986-02-13 1987-08-15 Asahi Denka Kogyo Kk ステリン乳化乃至可溶化組成物
FR2620024B1 (fr) 1987-09-09 1991-03-15 Dermatologiques Et Composition cosmetique comportant un agent antiradicaux libres, et agent correspondant
US5362732A (en) * 1989-12-20 1994-11-08 University Of North Carolina At Chapel Hill Boronated compounds
EP0594612B2 (en) 1991-05-03 2010-02-24 Raisio Nutrition Ltd. Process for the preparation of a substance comprising a beta-sitostanol fatty acid ester or a mixture thereof
US5352458A (en) 1992-12-21 1994-10-04 Applied Genetics Inc. Tanning method using DNA repair liposomes
KR970008132B1 (ko) 1993-02-08 1997-05-21 전동원 생체 임상의학용 키틴 및 키토산 제조방법
US5470577A (en) 1993-07-07 1995-11-28 Trustees Of Boston University Stimulation of tanning by DNA fragments or single-stranded DNA
DE4323615A1 (de) 1993-07-12 1995-01-19 Schreiner Edelgard Mittel gegen vorzeitiges Altern der Haut
DE4442987C2 (de) 1994-12-02 1997-04-17 Henkel Kgaa Kationische Chitinabbauprodukte

Also Published As

Publication number Publication date
JP2001504505A (ja) 2001-04-03
AU714993B2 (en) 2000-01-13
NO992562D0 (no) 1999-05-27
EP0952837B1 (de) 2002-09-18
EP0952837A1 (de) 1999-11-03
AU5553198A (en) 1998-06-22
AU713665B2 (en) 1999-12-09
EP0941097A1 (de) 1999-09-15
US6383514B1 (en) 2002-05-07
NO992564D0 (no) 1999-05-27
JP2001508046A (ja) 2001-06-19
WO1998023277A1 (de) 1998-06-04
ES2182137T3 (es) 2003-03-01
NO992562L (no) 1999-05-27
DK0941097T3 (da) 2002-08-19
NO992564L (no) 1999-05-27
EP0941097B1 (de) 2002-05-02
AU5322998A (en) 1998-06-22
DK0952837T3 (da) 2003-01-27
WO1998023275A1 (de) 1998-06-04
NZ335990A (en) 2000-10-27
CA2272754A1 (en) 1998-06-04
CA2273341A1 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
PT893992E (pt) Formas de dosagem oral de desintegracao rapida
ES2156839T1 (es) Medicamento que contiene alginato e implante para tratar la fibrosis.
ES513159A0 (es) "procedimiento para la preparacion de polipeptidos inmunogenamente activos y producidos microbianamente, para la obtencion de una vacuna contra la fiebre aftosa".
EA199800946A1 (ru) Концентрированный препарат антител
YU49279B (sh) Postupak za pripremanje farmaceutske formulacije za dobijanje leka za inhalacionu primenu
DE3484779D1 (de) Pharmazeutische mittel.
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
AR240250A1 (es) Procedimiento para la preparacion de una nueva formualcion farmaceutica oral que contiene omeprazol como ingrediente activo.
ES551119A0 (es) Procedimiento para preparar un agente analgesicamente activo a base de 2-amino-3-carboetoxiamino-6-(4-fluorobencilamino)-piridina y por lo menos un agente antiflogistico no esteroidal
NO970067D0 (no) Nytt farmasöytisk preparat for smertebehandling
ES2094823T3 (es) Pasta dentifrica antimicrobiana.
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
ES2163461T3 (es) Procedimiento para la obtencion de comprimidos efervescentes.
ATE59549T1 (de) Verpamil in dosierungskapsel.
NL970029I2 (nl) Benzimidazoolderivaten, bereiding en therapeutische toepassing.
SE9700885D0 (sv) New pharmaceutical formulation
ES2160410T3 (es) Preparados de complejos de protrombina inmunotolerantes.
NO914242D0 (no) Tyggegummi, samt fremgangsmaate for fremstilling av en slik
ATE361122T1 (de) Zahnpflegemittel in portionskapseln
SE8400723D0 (sv) Farmaceutisk komposition
TR199801298T2 (xx) ACE-engelleyicinin dispeptik semptomlar�n tedavisinde yeni t�bbi kullan�m�.
ES555150A0 (es) Un procedimiento para la preparacion de una solucion etanolica contra la caida del cabello, a base de extractos naturales de plantas
FI821324L (fi) Oxazolderivat
ES2179302T3 (es) Formas galenicas y sus utilizaciones.
ES2019634B3 (es) Terapia con clorfeniramina.